377 related articles for article (PubMed ID: 28770686)
21. Testosterone supplementation therapy for older men: potential benefits and risks.
Gruenewald DA; Matsumoto AM
J Am Geriatr Soc; 2003 Jan; 51(1):101-15; discussion 115. PubMed ID: 12534854
[TBL] [Abstract][Full Text] [Related]
22. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
Strawford A; Barbieri T; Van Loan M; Parks E; Catlin D; Barton N; Neese R; Christiansen M; King J; Hellerstein MK
JAMA; 1999 Apr; 281(14):1282-90. PubMed ID: 10208143
[TBL] [Abstract][Full Text] [Related]
23. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
24. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
[TBL] [Abstract][Full Text] [Related]
25. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
26. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE).
Isidori AM; Aversa A; Calogero A; Ferlin A; Francavilla S; Lanfranco F; Pivonello R; Rochira V; Corona G; Maggi M
J Endocrinol Invest; 2022 Dec; 45(12):2385-2403. PubMed ID: 36018454
[TBL] [Abstract][Full Text] [Related]
27. Testosterone replacement therapy improves QTaVI in hypogonadal men with spinal cord injury.
La Fountaine MF; Wecht JM; Cirnigliaro CM; Kirshblum SC; Spungen AM; Bauman WA
Neuroendocrinology; 2013; 97(4):341-6. PubMed ID: 23343764
[TBL] [Abstract][Full Text] [Related]
28. Testosterone and Resistance Training Improve Muscle Quality in Spinal Cord Injury.
Holman ME; Gorgey AS
Med Sci Sports Exerc; 2019 Aug; 51(8):1591-1598. PubMed ID: 30845047
[TBL] [Abstract][Full Text] [Related]
29. Hypotestosteronaemia in the aging male: should we treat it?
Christe N; Meier CA
Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486
[TBL] [Abstract][Full Text] [Related]
30. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.
Howell SJ; Radford JA; Adams JE; Smets EM; Warburton R; Shalet SM
Clin Endocrinol (Oxf); 2001 Sep; 55(3):315-24. PubMed ID: 11589674
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone.
Chrysant SG; Chrysant GS
Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348
[TBL] [Abstract][Full Text] [Related]
32. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
[TBL] [Abstract][Full Text] [Related]
33. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
[TBL] [Abstract][Full Text] [Related]
34. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
[TBL] [Abstract][Full Text] [Related]
35. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
Traish AM
Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
[TBL] [Abstract][Full Text] [Related]
36. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
Maganty A; Osterberg EC; Ramasamy R
Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
[TBL] [Abstract][Full Text] [Related]
37. Testosterone in older men after the Institute of Medicine Report: where do we go from here?
Harman SM
Climacteric; 2005 Jun; 8(2):124-35. PubMed ID: 16096168
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological regulation of the cholesterol transport machinery in steroidogenic cells of the testis.
Aghazadeh Y; Zirkin BR; Papadopoulos V
Vitam Horm; 2015; 98():189-227. PubMed ID: 25817870
[TBL] [Abstract][Full Text] [Related]
39. Testosterone treatment in the aging male: myth or reality?
Nigro N; Christ-Crain M
Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
[TBL] [Abstract][Full Text] [Related]
40. Alternatives to testosterone replacement: testosterone restoration.
McCullough A
Asian J Androl; 2015; 17(2):201-5. PubMed ID: 25578932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
